Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation. (Record no. 30293091)

MARC details
000 -LEADER
fixed length control field 01672 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518070353.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202012s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1499-3872
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.hbpd.2019.09.011
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Zhuang, Li
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20201210
245 00 - TITLE STATEMENT
Title Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Hepatobiliary & pancreatic diseases international : HBPD INT
Date of publication, distribution, etc. Feb 2020
300 ## - PHYSICAL DESCRIPTION
Extent 91-93 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision secondary
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Hepatocellular
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemoembolization, Therapeutic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fatal Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatectomy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immune Checkpoint Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Transplantation
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision secondary
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Programmed Cell Death 1 Receptor
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mou, Hai-Bo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Lan-Fang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhu, Heng-Kai
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yang, Zhe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liao, Qin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zheng, Shu-Sen
773 0# - HOST ITEM ENTRY
Title Hepatobiliary & pancreatic diseases international : HBPD INT
Related parts vol. 19
-- no. 1
-- p. 91-93
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.hbpd.2019.09.011">https://doi.org/10.1016/j.hbpd.2019.09.011</a>
Public note Available from publisher's website

No items available.